PANCREATIC CANCER SURVEILLANCE IN A HIGH-RISK COHORT: Is It Worth the Cost?
- 1 May 2000
- journal article
- Published by Elsevier in Medical Clinics of North America
- Vol. 84 (3) , 739-747
- https://doi.org/10.1016/s0025-7125(05)70255-8
Abstract
No abstract availableKeywords
This publication has 33 references indexed in Scilit:
- Hereditary pancreatitis: new insights, new directionsBest Practice & Research Clinical Gastroenterology, 1999
- MEK-1 plays an important role in EGF-induction and cAMP-mediated inhibition of ERK phosphorylation and G1åS phase transition in ductal pancreatic cancer cellsGastroenterology, 1998
- Serum islet amyloid polypeptide (IAPP) in pancreatic cancer (PC)-induced diabetes mellitus (DM): A screening test to detect PC in patients over 50 with new onset DMGastroenterology, 1998
- Hereditary Pancreatitis and the Risk of Pancreatic CancerJNCI Journal of the National Cancer Institute, 1997
- Molecular pathology of primary and metastatic ductal pancreatic lesionsCancer, 1997
- Endoscopic Ultrasonography: Current Indications and ApplicationsDigestive Diseases, 1995
- Long-Term Survival After Resection for Ductal Adenocarcinoma of the Pancreas Is It Really Improving?Annals of Surgery, 1995
- Medical Genetic Study of Eight Pancreatic Cancer-Prone FamiliesCancer Investigation, 1995
- Pancreatic CarcinomaNew England Journal of Medicine, 1992
- Diagnosis of Pancreatic CarcinomaPancreas, 1992